Journal
HYBRIDOMA
Volume 31, Issue 1, Pages 63-67Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/hyb.2011.0088
Keywords
-
Funding
- Chinese National Natural Science Foundation [30971138]
- Suzhou city international collaboration [SWH0926]
- Suzhou city scientific research [SWG0904, SS201004, SS201138]
- priority academic program development of Jiangsu Higher Education Institutions (PAPD)
Ask authors/readers for more resources
In this study, using an in vitro tube formation model, we observed that SZ117, a monoclonal antibody against matrix metalloproteinase-2 (MMP2), attenuated a capillary-like tube structure formed by tumor endothelial cell 3B11 and human sarcoma cell MG63. In addition, gelatin zymography showed that SZ117 markedly inhibited MMP2 activity, but did not affect the capability of MMP9-mediated gelatin degradation. These data suggest that SZ117 might have an anti-tumor angiogenic effect and that angiogenic tumor cells and MMP2 may be targeted by monoclonal antibodies for novel anti-tumor angiogenic and anti-cancerous drug discovery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
